Skip to main content
Market intelligence
ICCCHealthcare

Immucell Corp. insider activity

In the last 90 days, 1 corporate insider purchased $75,960 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$75,960
Corporate buyers
1
Latest transaction
Jun 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 18, 2026Boekhorst Paul Francis Olivier tePresident and CEOOpen Market Purchase8,000$9.50$75,960